Skip to content

Zhibo Hu

5 papers in the library · 29 citations · publishing 2023-2024

Papers

Sort Most recent Most cited

Effect of Repeated Intravenous Esketamine on Adolescents With Major Depressive Disorder and Suicidal Ideation: A Randomized Active-Placebo-Controlled Trial.

Journal of the American Academy of Child & Adolescent Psychiatry May 2024 Yanling Zhou, Xiaofeng Lan, Chengyu Wang et al.

Suicide is a major cause of death in adolescents with limited treatment options. Ketamine and its enantiomers have shown rapid anti-suicidal effects in adults with major depressive disorder (MDD), but their efficacy in adolescents is unknown. We conducted an active, placebo-controlled trial to determine the safety and efficacy of intravenous esketamine in this population. A total of 54...

Functional connectivity of the amygdala subregions and the antidepressant effects of repeated ketamine infusions in major depressive disorder.

European Psychiatry April 4, 2024 Haiyan Liu, Chengyu Wang, Xiaofeng Lan et al. 7 citations

Amygdala subregion-based network dysfunction has been determined to be centrally implicated in major depressive disorder (MDD). Little is known about whether ketamine modulates amygdala subarea-related networks. We aimed to investigate the relationships between changes in the resting-state functional connectivity (RSFC) of amygdala subregions and ketamine treatment and to identify important...

Short-term cognitive effects of repeated-dose esketamine in adolescents with major depressive disorder and suicidal ideation: a randomized controlled trial

Child and Adolescent Psychiatry and Mental Health September 14, 2023 Xiaofeng Lan, Chengyu Wang, Fan Zhang et al. 22 citations

BACKGROUND: Ketamine and its enantiomer have rapid and robust effects on depressive symptom and suicidal ideation. Little is known about their cognitive effects in adolescents. We aimed to evaluate the short-term effect of esketamine on cognition in adolescents with major depressive disorder (MDD) and suicidal ideation. METHOD: In this randomized-controlled trial, 51 participants aged 13-18...

Efficacy of repeated intravenous esketamine in adolescents with anxious versus non-anxious depression.

General Psychiatry June 21, 2023 Xiaofeng Lan, Chengyu Wang, Fan Zhang et al.

Background: Patients with anxious major depressive disorder (MDD) are more likely to have poorer outcomes than those with non-anxious MDD. However, the effect of esketamine on adolescents with anxious versus non-anxious MDD has remained unknown. Aims: We compared the efficacy of esketamine in adolescents with MDD and suicidal ideation, both anxious and non-anxious. Methods: Fifty-four...

DOI: 10.1136/gpsych-2023-101007 (opens in new tab) Full text (opens in new tab) Anxiety Suicidal ideation Adolescent psychiatry Depressive disorder, major

Ketamine-induced hippocampal functional connectivity alterations associated with clinical remission in major depression.

Journal of Affective Disorders 2023 Fan Zhang, Chengyu Wang, Xiaofeng Lan et al.

OBJECTIVE Hippocampal functional connectivity (FC) alterations, which may happen following ketamine treatment, play a key role in major depression remission. This study aims to investigate the resting-state FC changes of the hippocampus associated with clinical remission after repeated ketamine infusions. METHODS Forty-four major depressive patients received six intravenous ketamine (0.5 mg/kg)...